These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35946084)

  • 1. Future anti-HDV treatment strategies, including those aimed at HBV functional cure.
    Tan YC; Lee GH; Huang DQ; Lim SG
    Liver Int; 2023 Jun; 43(6):1157-1169. PubMed ID: 35946084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139-Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Anderson M; Gersch J; Holzmayer V; Elsner C; Krawczyk A; Kuhns MC; Cloherty G; Dittmer U; Vaillant A
    Hepatol Commun; 2021 Feb; 5(2):189-202. PubMed ID: 33553968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HBsAg isoform dynamics during NAP-based therapy of HBeAg-negative chronic HBV and HBV/HDV infection.
    Bazinet M; Anderson M; Pântea V; Placinta G; Moscalu I; Cebotarescu V; Cojuhari L; Jimbei P; Iarovoi L; Smesnoi V; Musteata T; Jucov A; Dittmer U; Gersch J; Holzmayer V; Kuhns M; Cloherty G; Vaillant A
    Hepatol Commun; 2022 Aug; 6(8):1870-1880. PubMed ID: 35368148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What will it take to cure hepatitis B?
    Jeng WJ; Lok ASF
    Hepatol Commun; 2023 Apr; 7(4):. PubMed ID: 36972391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HBsAg Loss as a Treatment Endpoint for Chronic HBV Infection: HBV Cure.
    Moini M; Fung S
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Therapies for Chronic Hepatitis B and the Potential for a Functional Cure.
    Chang ML; Liaw YF
    Drugs; 2023 Apr; 83(5):367-388. PubMed ID: 36906663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management and Treatment of Patients with Chronic Hepatitis B: Towards Personalized Medicine.
    Colombatto P; Coco B; Bonino F; Brunetto MR
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea.
    Kim HS; Kim SJ; Park HW; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Med Virol; 2011 Jul; 83(7):1172-7. PubMed ID: 21541950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of delta hepatitis.
    Gunsar F
    Expert Rev Anti Infect Ther; 2013 May; 11(5):489-98. PubMed ID: 23627855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy.
    Soriano V; Moreno-Torres V; Treviño A; Corral O; de Mendoza C
    Drug Des Devel Ther; 2023; 17():155-166. PubMed ID: 36712949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP-Based Therapy.
    Bazinet M; Anderson M; Pântea V; Placinta G; Moscalu I; Cebotarescu V; Cojuhari L; Jimbei P; Iarovoi L; Smesnoi V; Musteata T; Jucov A; Dittmer U; Gersch J; Holzmayer V; Kuhns M; Cloherty G; Vaillant A
    Hepatol Commun; 2021 Nov; 5(11):1873-1887. PubMed ID: 34558823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging anti-HDV drugs and HBV cure strategies with anti-HDV activity.
    Roca Suarez AA; Batbold E; Bartosch B; Dashdorj N; Testoni B; Zoulim F
    Liver Int; 2023 Aug; 43 Suppl 1():87-95. PubMed ID: 37017060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adventure of delta.
    Rizzetto M
    Liver Int; 2016 Jan; 36 Suppl 1():135-40. PubMed ID: 26725911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State-of-the-art and emerging antivirals for chronic hepatitis B infection.
    Papatheodoridi M; Papatheodoridis GV
    Expert Opin Pharmacother; 2022 Dec; 23(18):1999-2012. PubMed ID: 36329612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond bulevirtide: Alternative therapeutic options for the management of hepatitis delta virus.
    Asselah T
    J Viral Hepat; 2023 Apr; 30 Suppl 1():33-38. PubMed ID: 36529713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory Effect of IL-1β on HBV and HDV Replication and HBs Antigen-Dependent Modulation of Its Secretion by Macrophages.
    Delphin M; Faure-Dupuy S; Isorce N; Rivoire M; Salvetti A; Durantel D; Lucifora J
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of hepatitis B and delta coinfection in Israel.
    Shirazi R; Ram D; Rakovsky A; Bucris E; Gozlan Y; Lustig Y; Shaked-Mishan P; Picard O; Shemer-Avni Y; Ben-Zvi H; Halutz O; Lurie Y; Veizman E; Carlebach M; Braun M; Naftaly MC; Shlomai A; Safadi R; Mendelson E; Sklan EH; Ben-Ari Z; Mor O
    BMC Infect Dis; 2018 Feb; 18(1):97. PubMed ID: 29486716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome.
    Keskin O; Wedemeyer H; Tüzün A; Zachou K; Deda X; Dalekos GN; Heidrich B; Pehlivan S; Zeuzem S; Yalçın K; Gürel S; Tabak F; Idilman R; Bozkaya H; Manns M; Yurdaydin C
    Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2342-49.e1-2. PubMed ID: 26044319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding early serum hepatitis D virus and hepatitis B surface antigen kinetics during pegylated interferon-alpha therapy via mathematical modeling.
    Guedj J; Rotman Y; Cotler SJ; Koh C; Schmid P; Albrecht J; Haynes-Williams V; Liang TJ; Hoofnagle JH; Heller T; Dahari H
    Hepatology; 2014 Dec; 60(6):1902-10. PubMed ID: 25098971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohort.
    Bockmann JH; Grube M; Hamed V; von Felden J; Landahl J; Wehmeyer M; Giersch K; Hall MT; Murray JM; Dandri M; Lüth S; Lohse AW; Lütgehetmann M; Schulze Zur Wiesch J
    BMC Gastroenterol; 2020 Jan; 20(1):24. PubMed ID: 32000689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.